Literature DB >> 2159437

Association of oral contraceptive use and human papillomaviruses in invasive cervical cancers.

A Hildesheim1, W C Reeves, L A Brinton, C Lavery, M Brenes, M E De La Guardia, J Godoy, W E Rawls.   

Abstract

In a study of 197 cases of histologically confirmed invasive cervical cancer, 61% of biopsies were positive for human papillomavirus (HPV) DNA by Southern or dot-blot hybridization. An association between detection of HPV DNA and oral contraceptive use was observed when HPV-positive and -negative cases were compared. Women reporting recent or long-term (greater than 4 yrs) oral contraceptive use were at 2.3 and 2.9-fold increased risks of HPV positivity, respectively. An increased risk of HPV positivity was also associated with formal education and with urban residence, while long-term smoking was negatively associated with HPV detection. A non-significant trend of increasing risk of HPV positivity with increasing number of sexual partners of the women and of the male partners of monogamous women was observed. Detection of HPV DNA was not associated with other cervical cancer risk factors examined, including age at first coitus, number of pregnancies, and Pap smear screening history. Our findings suggest either an interaction between HPV infection and oral contraceptive use in the genesis of cervical cancer or an increased expression of HPV genome in neoplasms of oral contraceptive users. These observations also support a multifactorial model of cervical cancer causation.

Entities:  

Keywords:  Americas; Behavior; Biology; Cancer; Central America; Cervical Cancer; Contraception; Contraceptive Methods; Contraceptive Usage; Demographic Factors; Developing Countries; Diseases; Economic Factors; Educational Status; Family Planning; Infections; Latin America; Multiple Partners; Neoplasms; North America; Oral Contraceptives; Panama; Population; Population Characteristics; Previous Practice; Reproductive Tract Infections; Risk Factors; Sex Behavior; Sexual Partners; Sexually Transmitted Diseases; Smoking; Socioeconomic Factors; Socioeconomic Status; Urban Population; Viral Diseases

Mesh:

Substances:

Year:  1990        PMID: 2159437     DOI: 10.1002/ijc.2910450513

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  8 in total

1.  Oral contraceptive use and human papillomavirus infection in women without abnormal cytological results.

Authors:  G Veress; T Csiky-Mészáros; J Czeglédy; L Gergely
Journal:  Med Microbiol Immunol       Date:  1992       Impact factor: 3.402

2.  Multiple human papillomavirus type 16 glucocorticoid response elements functional for transformation, transient expression, and DNA-protein interactions.

Authors:  R Mittal; A Pater; M M Pater
Journal:  J Virol       Date:  1993-09       Impact factor: 5.103

Review 3.  Pathobiology of papillomavirus-related cervical diseases: prospects for immunodiagnosis.

Authors:  C P Crum; S Barber; J K Roche
Journal:  Clin Microbiol Rev       Date:  1991-07       Impact factor: 26.132

4.  From human papillomavirus (HPV) to cervical cancer: psychosocial processes in infection, detection, and control.

Authors:  S M Miller; W Mischel; A O'Leary; M Mills
Journal:  Ann Behav Med       Date:  1996

5.  Oral contraceptives and human papillomavirus infection in cervical intraepithelial neoplasia.

Authors:  G Gitsch; C Kainz; M Studnicka; A Reinthaller; G Tatra; G Breitenecker
Journal:  Arch Gynecol Obstet       Date:  1992       Impact factor: 2.344

6.  Prevalence of genital human papillomavirus infection in Wellington women.

Authors:  G E Meekin; M J Sparrow; R J Fenwicke; M Tobias
Journal:  Genitourin Med       Date:  1992-08

7.  Smoking, alcohol, sexual behaviour and drug use in women with cervical human papillomavirus infection.

Authors:  B Sikström; D Hellberg; S Nilsson; P A Mårdh
Journal:  Arch Gynecol Obstet       Date:  1995       Impact factor: 2.344

8.  Smoking, diet, pregnancy and oral contraceptive use as risk factors for cervical intra-epithelial neoplasia in relation to human papillomavirus infection.

Authors:  L Kjellberg; G Hallmans; A M Ahren; R Johansson; F Bergman; G Wadell; T Angström; J Dillner
Journal:  Br J Cancer       Date:  2000-04       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.